AHL vs GNW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, indicating significant operational and balance sheet concerns. Despite a low P/E of 5.48 and a Graham Number of $67.98—suggesting substantial undervaluation—the company's deteriorating liquidity (Current Ratio: 0.78, Quick Ratio: 0.35) and poor technical trend (10/100) raise red flags. Earnings growth is volatile, with recent Q/Q EPS contraction of -11.5% despite strong YoY gains, while insider sentiment is tepid at 40/100. The absence of a dividend and lack of Altman Z-Score further undermine confidence in stability.
Genworth Financial presents a classic value trap profile, characterized by a stable Piotroski F-Score of 4/9 and a significant discount to book value (P/B 0.40). While the Graham Number of $16.47 suggests substantial defensive value, this is heavily offset by an intrinsic value of $3.78 and a severe collapse in earnings growth (-63.6% YoY). The company maintains a strong liquidity position with a current ratio of 10.49, but stagnant revenue growth (0.10%) and thin profit margins indicate a lack of operational momentum. The divergence between the low P/B and the crashing EPS suggests the market is pricing in long-term structural headwinds despite recent short-term price gains.
Compare Another Pair
Related Comparisons
AHL vs GNW: Head-to-Head Comparison
This page compares Aspen Insurance Holdings Limite (AHL) and Genworth Financial, Inc. (GNW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.